Covid-19 pandemic: Global call for booster shot amid fresh Omicron curbs

Governments globally have tightened social mobility restrictions and made urgent pleas for citizens to vaccinate

Joe Biden
President Joe Biden told Americans worried about the Omicron variant that the country was “prepared” to fight it (Photo: Reuters)
ReutersBloomberg
2 min read Last Updated : Dec 23 2021 | 12:11 AM IST
Singapore suspended quarantine-free travel bookings and Australia boosted its readiness on Wednesday by announcing new vaccination funding for clinics and pharmacies. As surging Omicron infections just days before Christmas forced authorities to impose new curbs and expedite booster shots, Israel said it would administer a fourth dose of coronavirus vaccine to people over the age of 60 and medical personnel. It has become the first nation in the world to do so on such a widespread basis. 

Meanwhile, France’s health minister Olivier Veran said the country could soon have around 100,000 new Covid-19 cases a day, up from around 70,000 currently as the country battles a fifth wave of the epidemic.

Governments globally have tightened social mobility restrictions and made urgent pleas for citizens to vaccinate as Omicron emerges as the dominant strain of the coronavirus, upending reopening plans that many hoped would herald the start of a post-pandemic era in 2022.



In Hong Kong, Cathay Pacific Airways said it would cancel some passenger flights in January after the Asian financial centre tightened quarantine rules. Wednesday also saw Japan report its first suspected case of community transmission of Omicron. 

Countries are also looking to shorten the time between second vaccination shots and boosters. However, wary of public lockdown fatigue, there is reluctance to return to the strict curbs imposed during the spread of the Delta variant earlier this year. 

In fact, the British government  from Wednesday reduced the Covid-19 self-isolation period to seven days from 10 days for people in England who get a negative result on a lateral flow test two days in a row.


One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus VaccineUnited States

Next Story